Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies (2019)
- Authors:
- Autor USP: SHINJO, SAMUEL KATSUYUKI - FM
- Unidade: FM
- DOI: 10.1007/s00296-018-4215-x
- Subjects: ESTATINAS; DISLIPIDEMIAS; MIOSITE
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2019
- Source:
- Título: Rheumatology international
- ISSN: 0172-8172
- Volume/Número/Paginação/Ano: v. 39, n. 2, p. 311-316, 2019
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
BORGES, Isabela Bruna Pires e SHINJO, Samuel Katsuyuki. Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies. Rheumatology international, v. 39, n. 2, p. 311-316, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00296-018-4215-x. Acesso em: 11 mar. 2026. -
APA
Borges, I. B. P., & Shinjo, S. K. (2019). Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies. Rheumatology international, 39( 2), 311-316. doi:10.1007/s00296-018-4215-x -
NLM
Borges IBP, Shinjo SK. Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies [Internet]. Rheumatology international. 2019 ; 39( 2): 311-316.[citado 2026 mar. 11 ] Available from: https://doi.org/10.1007/s00296-018-4215-x -
Vancouver
Borges IBP, Shinjo SK. Safety of statin drugs in patients with dyslipidemia and stable systemic autoimmune myopathies [Internet]. Rheumatology international. 2019 ; 39( 2): 311-316.[citado 2026 mar. 11 ] Available from: https://doi.org/10.1007/s00296-018-4215-x - High prevalence of necrotizing myofibers in adult dermatomyositis muscle biopsies
- Rituximab as a treatment for human immunodeficiency virus-associated nemaline myopathy: What does the literature have to tell us?
- Clinical manifestations, outcomes, and antibody profile of Brazilian adult patients with dermatomyositis: a single-center longitudinal study
- Long-term effects of early pulse methylprednisolone and intravenous immunoglobulin in patients with dermatomyositis and polymyositis
- Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys
- Type 1 diabetes, COVID-19 vaccines and short-term safety: Subgroup analysis from the global COVAD study
- Cardiovascular manifestations in idiopathic inflammatory myopathies
- Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study
- Vaccine hesitancy in patients with autoimmune diseases. [Carta]: data from the coronavirus disease-2019 vaccination in autoimmune diseases study
- Different clinical phenotypes in anti-melanoma differentiation-associated protein 5-associated positive dermatomyositis
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
